Shares of Sun Pharmaceutical Industries experienced a decline of 0.95% to Rs 1,715.30 during today's session, accompanied by a traded volume of 1,270,902 shares. The stock is one of the NIFTY 50 STOCKS.
Financial Overview
A review of Sun Pharmaceutical Industries' financial performance reveals the following trends:
Revenue
The company's revenue demonstrates consistent growth over the quarters:
- Dec 2023: Rs 12,380.70 Cr
- Mar 2024: Rs 11,982.90 Cr
- Jun 2024: Rs 12,652.75 Cr
- Sep 2024: Rs 13,291.39 Cr
- Dec 2024: Rs 13,675.46 Cr
Net profit figures also show an upward trajectory:
- Dec 2023: Rs 2,568.03 Cr
- Mar 2024: Rs 2,666.59 Cr
- Jun 2024: Rs 2,871.25 Cr
- Sep 2024: Rs 3,030.67 Cr
- Dec 2024: Rs 2,917.54 Cr
Earnings per share have also seen increases:
- Dec 2023: 10.50
- Mar 2024: 11.10
- Jun 2024: 11.80
- Sep 2024: 12.70
- Dec 2024: 12.10
Analyzing the annual consolidated data provides further insights into the company's financial health.
Revenue
- 2020: Rs 32,837.50 Cr
- 2021: Rs 33,498.14 Cr
- 2022: Rs 38,654.49 Cr
- 2023: Rs 43,885.68 Cr
- 2024: Rs 48,496.85 Cr
- 2020: Rs 4,186.79 Cr
- 2021: Rs 2,284.68 Cr
- 2022: Rs 3,405.82 Cr
- 2023: Rs 8,560.84 Cr
- 2024: Rs 9,648.44 Cr
- 2020: 15.70
- 2021: 12.10
- 2022: 13.60
- 2023: 35.30
- 2024: 39.90
The following table summarizes key financial ratios for Sun Pharmaceutical Industries:
| Ratio | Value |
|---|---|
| Basic EPS (Rs.) | 39.90 |
| Diluted EPS (Rs.) | 39.90 |
| Book Value / Share (Rs.) | 279.69 |
| Dividend/Share (Rs.) | 13.50 |
| Face Value | 1 |
| Gross Profit Margin (%) | 29.64 |
| Operating Margin (%) | 24.37 |
| Net Profit Margin (%) | 19.89 |
| Return on Equity (%) | 15.04 |
| ROCE (%) | 17.26 |
| Return On Assets (%) | 11.20 |
| Current Ratio (X) | 2.56 |
| Quick Ratio (X) | 1.98 |
| Debt to Equity (x) | 0.04 |
| Interest Coverage Ratios (X) | 60.29 |
| Asset Turnover Ratio (%) | 0.58 |
| Inventory Turnover Ratio (X) | 0.68 |
| 3 Yr CAGR Sales (%) | 20.32 |
| 3 Yr CAGR Net Profit (%) | 105.50 |
| P/E (x) | 40.62 |
| P/B (x) | 6.11 |
| EV/EBITDA (x) | 26.75 |
| P/S (x) | 8.02 |
Sun Pharmaceutical Industries, with its current price at Rs 1,715.30, has demonstrated a robust financial performance as reflected in its revenue, net profit, and key financial ratios.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
